• Home
  • Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance.

Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance.

Author List
O'Keefe RA, Bhola NE, Lee DS, Johnson DE, Grandis JR
Publication
PloS one
Publication ID (Profile URL)
https://researcherprofiles.org/profile/88521766
Publication Year
2020
PubMed ID
31914141
Publication Title
O'Keefe RA, Bhola NE, Lee DS, Johnson DE, Grandis JR. Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance. PLoS One. 2020; 15(1):e0227261.